MRI Drugs May Cause Death, Warns FDA

by Rathi Manohar on  September 10, 2010 at 5:48 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

Magnetic Resonance Imaging (MRI) involves three substances that could be the cause for a fatal, albeit rare condition, warned US Food and Drug Administration (FDA).
 MRI Drugs May Cause Death, Warns FDA
MRI Drugs May Cause Death, Warns FDA

The FDA said new warnings for gadolinium-based contrast agents (GBCAs) needed to highlight the risk of nephrogenic systemic fibrosis (NSF) if the drug is given to certain patients with kidney disease.

The labels, said the agency, "will emphasize the need to screen patients to detect these types of kidney dysfunction before administration."

The three intravenous drugs involved in the FDA action are Magnevist, Omniscan, and Optimark, which are used ahead of MRIs to help detect abnormalities of body organs, blood vessels and other tissues.

Source: AFP

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Magnetic Resonance Imaging Drugs Banned in India Hearing Loss Functional Magnetic Resonance Imaging 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

Advertisement

News Category

News Archive